Compare · MDLN vs PFSA
MDLN vs PFSA
Side-by-side comparison of Medline Inc. (MDLN) and Profusa Inc. (PFSA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and PFSA operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $46.86B, about 15473.1x PFSA ($3.0M).
- PFSA has been more active in the news (16 items in the past 4 weeks vs 12 for MDLN).
- MDLN has more recent analyst coverage (25 ratings vs 0 for PFSA).
- Company
- Medline Inc.
- Profusa Inc.
- Price
- $35.10-1.52%
- $4.42-10.63%
- Market cap
- $46.86B
- $3.0M
- 1M return
- -
- +13.65%
- 1Y return
- -
- -99.86%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- News (4w)
- 12
- 16
- Recent ratings
- 25
- 0
Latest MDLN
- SEC Form 4 filed by Chief Executive Officer Boyle James M
- SEC Form 4 filed by Chief Operating Officer Miller Stephen L
- Large owner Gic Private Ltd sold $57,280,000 worth of shares (1,600,000 units at $35.80) (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.
- Large owner Gic Private Ltd sold $21,002,305 worth of shares (590,284 units at $35.58) (SEC Form 4)
- Large owner Mozart Holdco, Inc. converted options into 500,000 shares and disposed of 500,000 units of Class B Common Stock, increasing direct ownership by 81,083% to 233,520,656 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.
- Large owner Gic Private Ltd sold $79,971,448 worth of shares (2,248,612 units at $35.56) (SEC Form 4)
- SEC Form SCHEDULE 13G filed by Medline Inc.
- SEC Form 10-Q filed by Medline Inc.
Latest PFSA
- Profusa Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
- Profusa Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Profusa Announces Q2 2026 Financial Results and Progress on the Option Agreement Conditions to Close with G3 Vision Labs, a Commercial Stage Diagnostics Company
- Chief Financial Officer Knechtel Fred S. converted options into 301,991 shares (SEC Form 4)
- Chief Executive Officer Stover Jack E converted options into 301,991 shares (SEC Form 4)
- SEC Form 10-Q filed by Profusa Inc.
- Large owner Hrt Financial Lp sold $109,266 worth of shares (18,395 units at $5.94), closing all direct ownership in the company (SEC Form 4)
- SEC Form PRE 14A filed by Profusa Inc.
- Large owner Hrt Financial Lp sold $2,853 worth of shares (3,163 units at $0.90), decreasing direct ownership by 4% to 71,035 units (SEC Form 4)
- Large owner Hrt Financial Lp bought $5,384 worth of shares (5,585 units at $0.96) and sold $37,661 worth of shares (42,411 units at $0.89), decreasing direct ownership by 33% to 74,198 units (SEC Form 4)